In specialised translation, proofreading is often seen as the final administrative step in the process – little more than a last minute check to catch typos before delivery. In reality, its role goes far beyond that.
In industries such as pharmaceuticals, medical devices, biotechnology, clinical research and dermocosmetics, a translation may be linguistically accurate and still not be ready for publication, submission to a regulatory authority, review by a Notified Body or printing on product packaging.
Proofreading is the final quality checkpoint before a document reaches its intended audience. When content has implications for patient safety, regulatory compliance or a company’s scientific reputation, that final check is not a luxury – it is an essential risk management measure.
Revision, Proofreading and Linguistic QA: What’s the Difference?
Although the terms are often used interchangeably, revision, proofreading and linguistic quality assurance (QA) refer to different stages of the translation process, each with a distinct purpose.
Revision involves comparing the translated text against the source document to ensure that the content has been transferred accurately. The reviewer checks for omissions, mistranslations, terminology errors, false friends and any deviation from the purpose or intent of the original.
For example,in instructions for use, revision confirms that warnings, contraindications and operating procedures convey exactly the same meaning as the source text. In a Summary of Product Characteristics (SmPC) or Package Leaflet (PL), it ensures that indications, dosage, administration schedules, target populations and safety information have not been altered during translation.
Proofreading, on the other hand, is typically carried out once the document has been typeset or is close to its final layout. At this stage, the focus shifts from the translation itself to the document as a finished publication. Proofreaders verify spelling, line breaks, formatting, visual consistency, numbering, units of measurement, symbols, tables, callouts, cross-references, footnotes, punctuation, spacing, headers and footers.
This is the stage where issues such as the following are identified:
- a word split incorrectly on a product label;
- a unit of measurement separated from its numerical value;
- a warning misplaced during the artwork process;
- a symbol omitted during desktop publishing;
- a misaligned table;
- an internal cross-reference that no longer matches the final document;
- a sentence that is linguistically correct but becomes unclear once presented in its final layout.
Linguistic QA, or linguistic quality assurance, is broader still. It combines automated and human checks to identify issues relating to terminology, numbers, inconsistent segments, variables, tags, formatting, style guide compliance and consistency across documents. In multilingual projects, linguistic QA plays a vital role in ensuring consistency across languages, document versions and product portfolios.
In simple terms, revision validates the translation against the source text; proofreading validates the final published document; and linguistic QA helps identify systematic risks before, during and after the translation process.
In regulated industries, these three quality layers complement one another. They are not interchangeable they work together to deliver a reliable final product.
Levels of Revision: Proofreading, Stylistic and Technical Review
Not all revisions are carried out to the same depth. The level of review required depends on the type of document, the level of risk involved and its intended use. Some projects require only a basic editorial check, while others demand a far more specialised level of scrutiny.
Proofreading focuses on the formal aspects of the text, including spelling, punctuation, capitalisation, spacing, abbreviations, symbols, units of measurement, quotation marks, italics, numbering and typographical conventions.
Although this may seem like a relatively minor stage, its importance should not be underestimated. In healthcare content, something as simple as a misplaced comma, an incorrect unit of measurement or an inconsistent abbreviation can lead to confusion. Moreover, visible errors in medical or regulatory documents can undermine confidence in the content itself. If the presentation appears careless, readers may also question the scientific accuracy behind it.
Stylistic review goes a step further. Its objective is to ensure that the text reads clearly, naturally and consistently, while remaining appropriate for its intended audience.
The editorial approach required for a patient information leaflet is very different from that of a presentation for healthcare professionals, a pharmacy product sheet or regulatory documentation submitted to a Notified Body. At this stage, proofreaders assess readability, flow, tone, consistency of wording and the cultural and functional suitability of the message.
In dermocosmetics, for example, stylistic editing helps eliminate wording that sounds overly literal or unnatural, ensuring that the final text reflects the language typically used within the pharmacy channel. In clinical trials, it plays a key role in making informed consent forms easier for patients to understand without compromising scientific or regulatory accuracy.
Technical review is the most critical level of revision for specialised content. It requires subject-matter expertise to assess terminology, scientific concepts, units of measurement, product names, indications, instructions for use, claims, regulatory context and consistency with previously approved documentation.
For medical devices, this may include instructions for use, labelling, technical documentation, post-market surveillance materials or documentation related to MDR and IVDR compliance. In the pharmaceutical sector, it may involve reviewing Summary of Product Characteristics (SmPCs), Package Leaflets (PLs), regulatory variations, scientific materials or documentation submitted to health authorities. In clinical research, it often covers informed consent forms, questionnaires, study protocols and documentation for ethics committees.
The greater the potential impact of a document on patient safety, regulatory compliance or decision-making, the less appropriate it becomes to treat proofreading as a simple editorial check.
ISO 17100 and the Role of the Second Linguist
ISO 17100 is the internationally recognised standard for translation services, and one of its core principles is that a professional translation should never rely solely on the work of a single translator. Instead, it requires a controlled process involving qualified professionals and an independent revision carried out by a second linguist.
This second linguist plays a particularly important role in regulated industries. Their contribution goes far beyond simply giving the text “another read”. They provide an independent layer of quality control that helps identify interpretation errors, terminology inconsistencies and unsuitable linguistic choices that the original translator may have overlooked.
For Regulatory Affairs and Quality professionals, this has clear practical value. It ensures that the translation process is traceable, defensible and aligned with an established quality management system. Translation becomes an integral part of the product’s documentation lifecycle rather than an isolated linguistic task.
At Lexic, this is precisely where we add value. Our approach is not based simply on producing accurate translations, but on implementing robust linguistic workflows specifically designed for regulated industries where errors can affect compliance, patient safety, regulatory inspections, launch timelines and a company’s scientific credibility.
When Is Proofreading Essential?
Proofreading adds value to almost any translation project, but there are situations where it should be regarded as an essential part of the quality asurance process rather than an optional extra.
The first is labelling and packaging. Once translated text is placed into its final artwork, new risks emerge that simply do not exist in a bilingual review file. Line breaks, limited space, symbols, pictograms, tables, claims, warnings and visual hierarchy can all introduce errors that only become apparent in the finished layout. In pharmaceuticals, medical devices and dermocosmetics, even a minor mistake on packaging can result in costly reprints, launch delays or market complaints.
The second is instructions for use and technical documentation. Here, linguistic accuracy alone is not enough. Users must clearly understand what to do, in what order, under which precautions and what risks may be involved. An ambiguous instruction, an incorrect cross-reference or a poorly positioned warning can directly affect the safe use of a product.
The third is regulatory documentation. Regulatory submissions, technical files, annexes, responses to health authorities and documentation intended for Notified Bodies all require absolute consistency. In these projects, proofreading helps ensure that the final documents accurately reflect approved terminology, remain consistent across all supporting documentation and are ready for external review. A single inconsistency can generate additional questions, delay approvals or require last-minute revisions.
The fourth is clinical trial documentation. Informed consent forms, patient facing materials, questionnaires, study protocols and ethics committee submissions must be clear, consistent and easy to understand while maintaining complete scientific accuracy. Even relatively minor errors can delay approvals, complicate patient recruitment or create uncertainty for investigators and participants.
The fifth is medical communications and dermocosmetic marketing materials. These documents must strike a careful balance between scientific accuracy, commercial effectiveness, brand voice and regulatory requirements. Proofreading helps eliminate wording that sounds translated, identifies poorly adapted claims and ensures that the content feels natural and credible for the target market.
Finally, large multilingual projects deserve particular attention. As the number of languages, document versions and stakeholders increases, so does the complexity of maintaining consistency. The greatest risk is often not an individual translation error, but inconsistencies between versions, outdated terminology, conflicting revisions or the accidental publication of an incorrect file. Proofreading provides a final safeguard before documents are released.
How Does Proofreading Affect Cost and Timelines?
Proofreading involves both time and cost. The more important question, however, is not how much it costs to include it, but how much it could cost to leave it out.
For straightforward projects, adding a proofreading stage may appear to be an unnecessary expense. In regulated industries, however, the real cost of omitting it often becomes apparent later—in the form of reprints, launch delays, additional questions from regulatory authorities, distributor complaints, internal rework or a loss of confidence in the quality of the documentation.
It is also worth distinguishing between visible costs and hidden costs. The visible cost is the fee for proofreading itself. The hidden cost is the time spent by Regulatory Affairs, Quality, Marketing, Clinical or Export teams correcting documents, comparing versions, resolving terminology queries and dealing with avoidable issues immediately before a critical milestone.
When proofreading is built into the project plan from the outset, its impact on delivery schedules is generally predictable and manageable. When it is left until the very end—or omitted altogether—it often becomes an urgent and disruptive exercise.
For this reason, proofreading should be planned from the start of any international launch, regulatory submission, labelling update or multilingual communication project.
The key is to match the level of proofreading to the level of risk. Not every document requires the same depth of review, but high impact content always benefits from a final quality check before it is published, printed, submitted or shared with external stakeholders.
In specialised translation, proofreading is not about achieving stylistic perfection. It is about protecting patient safety, ensuring regulatory compliance, preserving scientific credibility and safeguarding the integrity of the final documentation.
That is why proofreading should not be regarded as an optional add-on. Whenever a document has real regulatory, scientific or commercial consequences, it should be considered an integral part of the translation process.
In regulated industries, the real question is not, “Can we afford to proofread this?” It is, “Can we afford not to?”
